The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cellsJean J. Zhao(Harvard University), Thomas M. Roberts(Dana-Farber Cancer Institute)Proceedings of the National Academy of SciencesDecember 8, 200510.1073/pnas.0508988102Cited by 327SaveCiteExport RISWatch citationsRelated PapersCOT drives resistance to RAF inhibition through MAP kinase pathway reactivation|Nature|2010|1.4kMedulloblastoma exome sequencing uncovers subtype-specific somatic mutations|Nature|2012|770Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene|Cell|2007|628The metabolic function of cyclin D3–CDK6 kinase in cancer cell survival|Nature|2017|354Lactate regulates cell cycle by remodelling the anaphase promoting complex|Nature|2023|200